SQI Q1 Net Loss Improves to $1.7M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SQI Diagnostics reported late Thursday a net loss of C$1.7 million (US$1.7 million), or C$.05 per share, in its fiscal first quarter, down from a net loss of C$2.3 million, or C$.07 per share, from a year ago.

The company did not disclose revenues for the period and figures were not yet available on the SEDAR website, which provides financial reports for publicly traded Canadian companies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.